(Q40478045)

20 September 2017

Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast. (English)

1 reference

20 September 2017

Kerry L Ross

1

1 reference

PubMed ID

15464425

20 September 2017

Charity N Davis

series ordinal

2

1 reference

PubMed ID

15464425

20 September 2017

Judith L Fridovich-Keil

series ordinal

3

1 reference

20 September 2017

1 September 2004

1 reference

Molecular Genetics and Metabolism

20 September 2017

1 reference

20 September 2017

83

1 reference

20 September 2017

1-2

1 reference

20 September 2017

103-116

1 reference

The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose.

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Structure and function of enzymes of the Leloir pathway for galactose metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

The enzymic conversion of glucosamine to galactosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactosaemia and allelic variation at the galactose-1-phosphate uridyltransferase gene: a complex relationship between genotype and phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Long‐term prognosis in galactosaemia: Results of a survey of 350 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

A patient with severe type of epimerase deficiency galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Generalised uridine diphosphate galactose-4-epimerase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactose-1-phosphate in the pathophysiology of galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Insights into the pathogenesis of galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Multiple copies of MRG19 suppress transcription of the GAL1 promoter in a GAL80-dependent manner in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Overexpression of human UDP-glucose pyrophosphorylase rescues galactose-1-phosphate uridyltransferase-deficient yeast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Studies of the V94M-substituted human UDPgalactose-4-epimerase enzyme associated with generalized epimerase-deficiency galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

A method for the determination of changes of glycolytic metabolites in yeast on a subsecond time scale using extraction at neutral pH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Cleanup and Analysis of Sugar Phosphates in Biological Extracts by Using Solid-Phase Extraction and Anion-Exchange Chromatography with Pulsed Amperometric Detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Transcriptional control of the GAL/MEL regulon of yeast Saccharomyces cerevisiae: mechanism of galactose-mediated signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

CLB5: a novel B cyclin from budding yeast with a role in S phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Evidence for accessory pathway of galactose metabolism in mammalian liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Evidence for alternate galactose oxidation in a patient with deletion of the galactose-1-phosphate uridyltransferase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Oxidation of galactose by galactose-1-phosphate uridyltransferase-deficient lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

UDPgalactose epimerase in lens and fibroblasts: activity expression in patients with cataracts and mental retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Identification and characterization of a mutation, in the human UDP-galactose-4-epimerase gene, associated with generalized epimerase-deficiency galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

A mouse model of galactose-induced cataracts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

A study of galactokinase and glucose 4-epimerase from normal and galactosemic skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Developmental and tissue-specific modulation of rat galactose-1-phosphate uridyltransferase steady state messenger RNA and specific activity levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactose metabolism in human ovarian tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Selection and analysis of galactose metabolic pathway variants of a mouse liver cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Culture of galactosaemic fibroblasts in the presence of galactose: effect of inosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

A mouse model of galactose-1-phosphate uridyl transferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

The role of polyols in the pathophysiology of hypergalactosemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Galactose-1-phosphate is a regulator of inositol monophosphatase: a fact or a fiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Defective galactosylation of serum transferrin in galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Deficit of uridine diphosphate galactose in galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

The investigation of UDPGlucose and UDPGalactose concentration in red blood cells of patients with classical galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

UDP-glucose and UDP-galactose concentrations in cultured skin fibroblasts of patients with classical galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

HPLC analysis of uridine diphosphate sugars: decreased concentrations of uridine diphosphate galactose in erythrocytes and cultured skin fibroblasts from classical galactosemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

Nucleotide sugars: determination of cellular levels and discrepancies in results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.07.005

10.1016/J.YMGME.2004.07.005

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

15464425